- Smoking cessation and nicotine de-addiction products, including nicotine replacement therapies (NRTs), pharmacological treatments, and behavioral therapies, are critical in addressing tobacco dependence and promoting healthier lifestyles globally
- The market is propelled by rising health consciousness, stricter anti-smoking regulations, and increasing adoption of innovative cessation aids such as e-cigarettes and digital therapy platforms
- North America dominated the market with the largest revenue share of 42.5% in 2024, driven by high awareness levels, robust healthcare infrastructure, and significant investments in smoking cessation programs
- Asia-Pacific is anticipated to be the fastest-growing region during the forecast period, fueled by rising disposable incomes, increasing urbanization, and growing anti-smoking initiatives in countries such as China and India
- The Nicotine Replacement Therapy (NRT) Products segment dominated the largest market revenue share of 68.5% in 2024, driven by its proven effectiveness, wide availability, and over-the-counter accessibility
